Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Incheon-Bucheon Cohort of Patients Undergoing Primary PCI for Acute STEMI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02804958
Recruitment Status : Completed
First Posted : June 17, 2016
Last Update Posted : June 17, 2016
Sponsor:
Collaborators:
Soon Chun Hyang University
Sejong General Hospital
Inha University Hospital
Information provided by (Responsible Party):
Woong Chol Kang, Gachon University Gil Medical Center

Brief Summary:
INcheon-Bucheon cohorT of patients undERgoing primary percutaneous coronary intervention for acute ST-ELevation myocardiaL infARction (INTERSTELLAR) registry is a retrospective, observational, 4-regional-hospital based registry reflecting current practices of management, risk factors, and clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention at cities of Incheon and Bucheon located in the mid-western part of the Korean peninsula between 2007 and 2014.

Condition or disease Intervention/treatment
Myocardial Infarction Procedure: STEMI treated with primary PCI

Detailed Description:

INcheon-Bucheon cohorT of patients undERgoing primary percutaneous coronary intervention for acute ST-ELevation myocardiaL infARction (INTERSTELLAR) registry is a retrospective, observational, 4-regional-hospital based registry reflecting current practices of management, risk factors, and clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) at cities of Incheon and Bucheon located in the mid-western part of the Korean peninsula between 2007 and 2014. Diagnosis of acute STEMI was based on clinical data findings including typical symptoms, 12-lead electrocardiography, and blood test. Decisions regarding primary PCI were made by at least 2 attending cardiologists at the time of presentation.

Demographic data, cardiovascular risk factors, laboratory data and clinical follow-up data were collected. Baseline blood test was obtained and recorded as part of the routine care for patients who visited the emergency room for chest pain and in whom acute coronary syndrome was suspected. Standard medical management was provided by responsible physicians.

Layout table for study information
Study Type : Observational
Actual Enrollment : 1537 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Incheon-Bucheon Cohort of Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-segment Elevation Myocardial Infarction
Study Start Date : December 2014
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack

Group/Cohort Intervention/treatment
STEMI treated with primary PCI
Patients diagnosed with acute ST-segment elevation myocardial infarction and treated with primary percutaneous coronary intervention were consecutively registered.
Procedure: STEMI treated with primary PCI
Primary percutaneous coronary intervention was performed according to the current standard guidelines. Coronary angiography was performed using standard techniques. The use of thrombectomy devices, intravascular ultrasound, intra-aortic balloon pump, and percutaneous cardiopulmonary support was up to the operator.




Primary Outcome Measures :
  1. MACCE [ Time Frame: Within the 1 year ]
    Major adverse cardiac and cerebrovascular event (MACCE), defined as the composite of all-cause death, non-fatal myocardial infarction and non-fatal stroke


Secondary Outcome Measures :
  1. All-cause death [ Time Frame: Within the 1 year ]
  2. Non-fatal myocardial infarction [ Time Frame: Within the 1 year ]
  3. Non-fatal stroke [ Time Frame: Within the 1 year ]
  4. Ischemic-driven revascularization [ Time Frame: Within the 1 year ]
  5. Admission for heart failure [ Time Frame: Within the 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients diagnosed with acute ST-segment elevation myocardial infarction (STEMI) and treated with primary percutaneous coronary intervention (PCI) were consecutively registered. Diagnosis of acute STEMI was based on clinical data findings including typical symptoms, 12-lead electrocardiography, and blood test. Decisions regarding primary PCI were made by at least 2 attending cardiologists at the time of presentation.
Criteria

Inclusion Criteria:

  • Patients diagnosed with acute ST-segment elevation myocardial infarction
  • Patients treated with primary percutaneous coronary intervention

Exclusion Criteria:

  • Patients diagnosed with Non-ST-segment elevation acute coronary syndrome
  • Patients treated with thrombolytic therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02804958


Locations
Layout table for location information
Korea, Republic of
Sejong General Hospital
Bucheon, Korea, Republic of
Soon Chun Hyang University Bucheon Hospital
Bucheon, Korea, Republic of
Gachon University Gil Medical Center
Incheon, Korea, Republic of
Inha University Hospital
Incheon, Korea, Republic of
Sponsors and Collaborators
Gachon University Gil Medical Center
Soon Chun Hyang University
Sejong General Hospital
Inha University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Woong Chol Kang, MD Gachon University Gil Medical Center
Study Data/Documents: Clinical Study Report  This link exits the ClinicalTrials.gov site
Identifier: INTERSTELLAR-Stature
Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction

Layout table for additonal information
Responsible Party: Woong Chol Kang, Professor, Gachon University Gil Medical Center
ClinicalTrials.gov Identifier: NCT02804958    
Other Study ID Numbers: INTERSTELLAR
First Posted: June 17, 2016    Key Record Dates
Last Update Posted: June 17, 2016
Last Verified: June 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Woong Chol Kang, Gachon University Gil Medical Center:
ST-segment elevation myocardial infarction
Primary percutaneous coronary intervention
Clinical outcomes
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
ST Elevation Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases